Cardiac stress testing and coronary artery disease in liver transplantation candidates: Meta-analysis

Jonathan Soldera1, Fábio Camazzola1, Santiago Rodríguez2

  • 1School of Medicine, Universidade de Caxias do Sul (UCS), Caxias do Sul 95070-560, Brazil.

World Journal of Hepatology
|December 12, 2018
PubMed

Insights

Dobutamine stress echocardiography (DSE) and myocardial perfusion scintigraphy (MPS) show low sensitivity for detecting coronary artery disease (CAD) in liver transplant candidates. While specific, these tests are insufficient for ruling out CAD in this population.

Area of Science:

  • Cardiology
  • Hepatology
  • Diagnostic Imaging

Background:

  • Coronary artery disease (CAD) is a significant concern in patients with cirrhosis awaiting liver transplantation (LT).
  • Non-invasive diagnostic tests are crucial for assessing CAD risk before LT.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of dobutamine stress echocardiography (DSE) and myocardial perfusion scintigraphy (MPS) for predicting CAD.
  • To compare DSE and MPS against invasive coronary angiography (ICA) as the gold standard in cirrhotic patients.

Main Methods:

  • Systematic literature search across multiple databases (Scopus, Web of Science, PubMed, etc.) without date or language restrictions.
  • Manual searching of reference lists for relevant studies.
  • Inclusion of 10 studies for DSE and 10 for MPS in the final meta-analysis.

Main Results:

  • Pooled sensitivity for DSE was 28% and for MPS was 61%.
  • Pooled specificity was 82% for DSE and 74% for MPS.
  • Both DSE and MPS demonstrated significant specificity but inadequate sensitivity for CAD diagnosis.

Conclusions:

  • Dobutamine stress echocardiography (DSE) and myocardial perfusion scintigraphy (MPS) lack sufficient sensitivity to reliably rule out coronary artery disease (CAD).
  • Despite high specificity, these non-invasive tests are not adequate for determining the presence of CAD in patients with cirrhosis considered for liver transplantation.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
443
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
267
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
372
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
687
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.0K